eMERGE Phase IV Clinical Center at Mass General Brigham
麻省总医院布里格姆分校 eMERGE IV 期临床中心
基本信息
- 批准号:10834530
- 负责人:
- 金额:$ 23.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdministrative SupplementAll of Us Research ProgramBaseline SurveysBiomedical ResearchBlack raceClinicalClinical TrialsCollectionCommunicationCommunication MethodsCommunication ResearchCommunication ToolsComprehensionConsentDataData CollectionDecentralizationDisparityEducationElectronic Health RecordElectronic MailElectronic Medical Records and Genomics NetworkEnsureEquityEthnic OriginFamilyGeneticGenomeGoalsHealthcareHispanicIndividualLanguageLatinoLearningLongitudinal StudiesMethodsModelingParticipantPhaseQuestionnairesRaceRecording of previous eventsReportingResearchRiskRisk FactorsSamplingSiteSourceSurveysTelephoneTextTimeTranslatingclinical centerclinical practicedisparity eliminationexperiencefollow-uphealth disparityhealth equityimprovednovelprogramsrecruitresponsesample collection
项目摘要
Abstract: To improve health equity in implementation of Genome Informed Risk Scores (GIRA)
in clinical practice, the eMERGE IV administrative supplement proposal leverages our expertise
from leading the All of Us Research Program retention campaign, and the MGB Decentralized
Clinical Trials Program, we are proposing to deploy novel communication methods and research
navigator workflows to enhance recruitment and retention in eMERGE. Specific aims: Aim 1:
Enhance equity in recruitment and return of GIRA results by employing novel communications
methods to diverse participants at baseline and at follow-up survey time points. We will develop
culturally sensitive new recruitment materials for Hispanic/Latino and Black participants, utilizing
plain language and graphics to explain study steps more clearly, explain that survey completion
is required to receive results and the importance of fully engaging at all points in this longitudinal
study. Our Spanish-speaking team will translate existing study materials to improve
comprehension by Hispanic/Latino participants. New and existing materials will be shared
throughout the eMERGE network to reduce survey data missingness and improve health equity.
Aim 2: Deploy a research navigator model with a diverse study team, to assign a navigator to
each participant, to guide and assist participants at each step in eMERGE from consent, survey
completion, sample collection, GIRA return, through collection of follow-up surveys. We will use
omni-channel communications based on participant choice (phone, text, email) and track
successful methods to inform the eMERGE network whether the navigator model with
personalized communication methods can be used at other sites. For participants who do not
complete surveys, we will perform chart reviews to collect key variables needed for GIRA to
increase the rate of equitable data collection and return of GIRA reports with minimal missing
data on demographic, clinical, and family history risk factors. Given the striking disparities in
data missingness the early phase of eMERGE IV by race and ethnicity, and the decision by the
network not to send samples for PRS analysis unless baseline survey data is provided by
participants, the study is at risk for introducing disparities in the return of results, thus biasing its
conclusions. Achieving health equity requires extra effort and focused methods to enhance
education, encourage full participation at each step of the program, provide assistance at an
individual level and gather data from available sources such as EHRs if we aim to eliminate
disparities in health and health care. Lessons learned in this administrative supplement will be
shared across the eMERGE network to enhance health equity of the entire study.
摘要:改善基因组知情风险评分实施健康平等(GIRA)
在临床实践中,出现的IV行政补充提案利用我们的专业知识
从领导我们所有的研究计划保留运动,以及MGB分散的
临床试验计划,我们建议部署新颖的交流方法和研究
导航器工作流程以增强出现的招聘和保留。具体目的:目标1:
通过采用新颖的沟通来提高GIRA结果的招聘和返回
在基线和后续调查时间点上的不同参与者的方法。我们将发展
使用文化敏感的西班牙裔/拉丁裔和黑人参与者的新招聘材料
简单的语言和图形可以更清楚地解释研究步骤,解释调查完成
必须接受结果,并且在这个纵向中的所有点都充分参与的重要性
学习。我们讲西班牙语的团队将翻译现有的学习材料以改进
西班牙裔/拉丁裔参与者的理解。新的和现有的材料将分享
在整个出现的网络中,以减少调查数据丢失并改善健康公平。
目标2:与多元化的研究团队一起部署研究导航器模型,将导航员分配给
每个参与者,指导和协助参与者在同意下出现的每个步骤,调查
通过收集后续调查,完成,样本收集,GIRA返回。我们将使用
基于参与者选择(电话,文本,电子邮件)和跟踪的全渠道通信
成功通知出现网络的成功方法是否使用导航器模型
个性化通信方法可以在其他站点使用。对于那些没有的参与者
完成调查,我们将执行图表评论,以收集Gira所需的关键变量
提高公平数据收集的速度和GIRA报告的回报率,而缺失最少
有关人口,临床和家族史风险因素的数据。考虑到明显的差异
数据缺失是种族和种族出现的IV的早期阶段,以及
除非提供基线调查数据,否则网络不发送样本进行PRS分析
参与者,该研究有可能在结果回报中引入差异的风险,从而使其偏见
结论。实现健康公平需要额外的努力和集中的方法来增强
教育,鼓励在计划的每个步骤中充分参与,并在
如果我们旨在消除个人级别,并从可用来源(例如EHR)收集数据
健康和卫生保健方面的差异。在这种行政补充中汲取的教训将是
在Emerge网络上共享,以增强整个研究的健康平等。
项目成果
期刊论文数量(49)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Vascular Geometry Associated with Anterior Communicating Artery Aneurysm Formation.
- DOI:10.1016/j.wneu.2020.11.160
- 发表时间:2021-03
- 期刊:
- 影响因子:2
- 作者:Zhang J;Can A;Lai PMR;Mukundan S Jr;Castro VM;Dligach D;Finan S;Gainer VS;Shadick NA;Savova G;Murphy SN;Cai T;Weiss ST;Du R
- 通讯作者:Du R
locStra: Fast analysis of regional/global stratification in whole-genome sequencing studies.
- DOI:10.1002/gepi.22356
- 发表时间:2021-03
- 期刊:
- 影响因子:2.1
- 作者:Hahn G;Lutz SM;Hecker J;Prokopenko D;Cho MH;Silverman EK;Weiss ST;Lange C;NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium
- 通讯作者:NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium
The Mass General Brigham Biobank Portal: an i2b2-based data repository linking disparate and high-dimensional patient data to support multimodal analytics.
- DOI:10.1093/jamia/ocab264
- 发表时间:2022-03-15
- 期刊:
- 影响因子:0
- 作者:Castro VM;Gainer V;Wattanasin N;Benoit B;Cagan A;Ghosh B;Goryachev S;Metta R;Park H;Wang D;Mendis M;Rees M;Herrick C;Murphy SN
- 通讯作者:Murphy SN
Genomic medicine in the military.
- DOI:10.1038/npjgenmed.2015.8
- 发表时间:2016
- 期刊:
- 影响因子:5.3
- 作者:De Castro M;Biesecker LG;Turner C;Brenner R;Witkop C;Mehlman M;Bradburne C;Green RC
- 通讯作者:Green RC
Association between inflammation and systolic blood pressure in RA compared to patients without RA.
与非 RA 患者相比,RA 患者炎症与收缩压之间的关联。
- DOI:10.1186/s13075-018-1597-9
- 发表时间:2018
- 期刊:
- 影响因子:4.9
- 作者:Yu,Zhi;Kim,SeoyoungC;Vanni,Kathleen;Huang,Jie;Desai,Rishi;Murphy,ShawnN;Solomon,DanielH;Liao,KatherineP
- 通讯作者:Liao,KatherineP
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELIZABETH W KARLSON其他文献
ELIZABETH W KARLSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELIZABETH W KARLSON', 18)}}的其他基金
eMERGE Phase IV Clinical Center at Partners HealthCare
Partners HealthCare 的 eMERGE IV 期临床中心
- 批准号:
10230561 - 财政年份:2020
- 资助金额:
$ 23.31万 - 项目类别:
A New England Enrollment Center for PMI Cohort Program
新英格兰 PMI 队列计划招生中心
- 批准号:
9453746 - 财政年份:2016
- 资助金额:
$ 23.31万 - 项目类别:
A New England Enrollment Center for PMI Cohort Program
新英格兰 PMI 队列计划招生中心
- 批准号:
9355397 - 财政年份:2016
- 资助金额:
$ 23.31万 - 项目类别:
EMERGE PHASE III CLINICAL CENTER AT PARTNERS HEALTHCARE
PARTNERS HEALTHCARE 新兴三期临床中心
- 批准号:
9493516 - 财政年份:2015
- 资助金额:
$ 23.31万 - 项目类别:
eMERGE Phase IV Clinical Center at Mass General Brigham
麻省总医院布里格姆分校 eMERGE IV 期临床中心
- 批准号:
10625354 - 财政年份:2015
- 资助金额:
$ 23.31万 - 项目类别:
相似海外基金
Establishing the PhenX Toolkit as a Biomedical Knowledgebase
将 PhenX 工具包建立为生物医学知识库
- 批准号:
10807362 - 财政年份:2022
- 资助金额:
$ 23.31万 - 项目类别:
Investigate interactive roles of environmental, behavioral and genetic factors on racial disparities in breast cancer outcomes
研究环境、行为和遗传因素对乳腺癌结果种族差异的交互作用
- 批准号:
10655049 - 财政年份:2021
- 资助金额:
$ 23.31万 - 项目类别:
Polygenic Risk Scores for Diverse Populations - Bridging Research and Clinical Care
不同人群的多基因风险评分 - 连接研究和临床护理
- 批准号:
10658157 - 财政年份:2020
- 资助金额:
$ 23.31万 - 项目类别:
Multi-modal Health Information Technology Innovations for Precision Management of Glaucoma
青光眼精准管理的多模式健康信息技术创新
- 批准号:
10660029 - 财政年份:2020
- 资助金额:
$ 23.31万 - 项目类别:
Hispanic/Latinxs coexisting chronic health conditions, mental illness and social determinants of health
西班牙裔/拉丁裔共存的慢性健康状况、精神疾病和健康的社会决定因素
- 批准号:
10654358 - 财政年份:1997
- 资助金额:
$ 23.31万 - 项目类别: